Inhibitors of CCR9 activity

Details for Australian Patent Application No. 2006328900 (hide)

Owner Novartis AG

Inventors Werner, Gudrun; Lehr, Philipp; Jaksche, Herbert; Winiski, Anthony; Carballido Herrera, Jose M.

Agent Davies Collison Cave

Pub. Number AU-A-2006328900

PCT Pub. Number WO2007/071440

Priority 0526255.5 22.12.05 GB

Filing date 22 December 2006

Wipo publication date 28 June 2007

International Classifications

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/071440 Priority application(s): WO2007/071440

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328901-Inhibitors of CCR9 activity

2006328899-Soluble IL-17RC variant and uses thereof